Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,144 | -19,243 | -120,717 | -84,616 | -56,942 |
| Depreciation Amortization | -1,153 | -417 | 709 | 517 | 317 |
| Accounts payable and accrued liabilities | -2,313 | -753 | -8,328 | -6,443 | -4,131 |
| Other Working Capital | -10,446 | -12,209 | 4,501 | -570 | -2,731 |
| Other Operating Activity | 11,184 | 5,781 | 34,500 | 19,164 | 12,096 |
| Operating Cash Flow | $-37,872 | $-26,841 | $-89,335 | $-71,948 | $-51,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -114,983 | -94,987 | N/A | N/A | N/A |
| PPE Investments | -6,665 | -4,406 | -6,399 | -4,541 | -275 |
| Investing Cash Flow | $-121,648 | $-99,393 | $-6,399 | $-4,541 | $-275 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,125 | 0 | 183 | 183 | 177 |
| Financing Cash Flow | $6,125 | $0 | $183 | $183 | $177 |
| Beginning Cash Position | 180,765 | 180,765 | 276,316 | 276,316 | 276,316 |
| End Cash Position | 27,370 | 54,531 | 180,765 | 200,010 | 224,827 |
| Net Cash Flow | $-153,395 | $-126,234 | $-95,551 | $-76,306 | $-51,489 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,872 | -26,841 | -89,335 | -71,948 | -51,391 |
| Capital Expenditure | -6,665 | -4,406 | -6,399 | -4,541 | -275 |
| Free Cash Flow | -44,537 | -31,247 | -95,734 | -76,489 | -51,666 |